Parteck® SRP 80
Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods. Its matrix diffusion technology helps increase the efficacy and bioavailability of your compound while reducing side effects and the risk of dose dumping. Parteck® SRP 80 is well suited for direct compression processes and helps accelerate your formulation work—from simplified feasib…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Great excipient for sustained release formulations
Pharmaceutical formulations
We've been testing this excipient in sustained release oral formulations and it seems to work very well. More importantly, it is compatible with a broad range of active pharmaceutical ingredients [salts, acids, bases and neutral species]. It comes with a very thorough C of A and Millipore's technical support has been OUTSTANDING!
Review Date: 1 Aug 2017 | Merck
Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods. Its matrix diffusion technology helps increase the efficacy and bioavailability of your compound while reducing side effects and the risk of dose dumping.
Parteck® SRP 80 is well suited for direct compression processes and helps accelerate your formulation work—from simplified feasibility and development to rapid and cost-efficient manufacturing.
Benefits of Parteck® SRP 80:
- Reliable sustained release profiles of active pharmaceutical ingredients over several hours
- Suitable for direct compression processes with conventional equipment
- Resistant to pH- and alcohol-induced dose dumping
- Superior batch-to-batch consistency and robust performance due to fully synthetic material
- Faster time to market with the Emprove® program
